Prelude Therapeutics Inc (PRLD) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $141.31M | -19.5% |
| 2024 | $175.51M | -36.8% |
| 2023 | $277.67M | +25.9% |
| 2022 | $220.50M | -27.7% |
| 2021 | $305.10M | +36.5% |
| 2020 | $223.59M | +922.3% |
| 2019 | $21.87M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $141.31M | -19.5% |
| 2024 | $175.51M | -36.8% |
| 2023 | $277.67M | +25.9% |
| 2022 | $220.50M | -27.7% |
| 2021 | $305.10M | +36.5% |
| 2020 | $223.59M | +922.3% |
| 2019 | $21.87M | — |